Antagonist Protocol in Poor Responders

Female Infertility Due to Diminished Ovarian Reserve Clinical Trial

Official title:
Does the Addition of Growth Hormone to the Invitro Fertilization/ Intracytoplasmic Sperm Injection Antagonist Protocol Improve Outcome in Poor Responders? A Randomized Controlled Trial

Status Completed

Clinical Trial Summary

The effect of use of the growth hormone with antagonist protocol on the outcome of the IVF/ICSI cycles in poor responders.

Clinical Trial Description

Two groups of poor responder female patients planned to receive the antagonist IVF/ICSI protocol are randomized to whether or not to add growth hormone to their protocol. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02195947
Study type	Interventional
Source	Cairo University
Contact
Status	Completed
Phase	Phase 4
Start date	July 2014
Completion date	July 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01915186` - Use of Dehydroepiandrosterone (DHEA) in Women With Normal and Poor Ovarian Reserve Undergoing IVF	N/A
Withdrawn	`NCT02209168` - Differences in Ovarian Reserve Markers and Vitamin D Between Infertile Indian, Arabian and Caucasian Population
Completed	`NCT02341365` - Vitamin D Influence on Oocyte Donation	N/A
Completed	`NCT02185326` - Microflare Protocol in Poor Responders	Phase 4
Completed	`NCT01897324` - IVF/ICSI Protocols in Poor Responders With Growth Hormone	Phase 4
Recruiting	`NCT02294500` - Cohort Study to Evaluate Ovarian Function	N/A
Recruiting	`NCT01662466` - Effect of Testosterone Treatment on Embryo Quality	Phase 1/Phase 2
Enrolling by invitation	`NCT02179255` - Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF	Phase 1/Phase 2